Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis
- 1 September 2001
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 139 (3) , 380-384
- https://doi.org/10.1067/mpd.2001.117577
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort studyThe Lancet, 1999
- Pathogenesis of infantile hypertrophic pyloric stenosis: recent progressPediatric Surgery International, 1998
- The epidemiology of infantile hypertrophic pyloric stenosisPaediatric and Perinatal Epidemiology, 1997
- Regulation of Migrating Motor Complexes by Motilin and Pancreatic Polypeptide in Human InfantsPediatric Research, 1997
- Using electronic medical records to predict mortality in primary care patients with heart diseaseJournal of General Internal Medicine, 1996
- The Epidemiology of Infantile Hypertrophic Pyloric Stenosis in New York StateArchives of Pediatrics & Adolescent Medicine, 1995
- Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptomsDigestive Diseases and Sciences, 1994
- Erythromycin and other macrolides as prokinetic agentsPublished by Elsevier ,1993
- Illnesses in Infants Born to Women With Chlamydia trachomatis InfectionAmerican Journal of Diseases of Children, 1985
- Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five casesJournal of Pediatric Surgery, 1976